Quinton (Ding Quan) Ng, PhD, BSc (Hon)
Cards
Education
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 48 Publications
- 447 Citations
- 17 Yale Co-Authors
Featured Publication
Education
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 48 Publications
- 447 Citations
- 17 Yale Co-Authors
Featured Publication
Education
University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
National University of Singapore, Pharmacy (2019)
Publications Overview
- 48 Publications
- 447 Citations
- 17 Yale Co-Authors
Featured Publication
About
Copy Link
Titles
Postdoctoral Associate
Biography
Quinton Ng, PhD, BScPharm(Hons), is a postdoctoral researcher on the Yale Cancer Center Decision Science Team and Goshua Lab. A pharmacist by training and a pharmacoepidemiologist, he focuses on health outcomes research with a deep commitment to ensuring equitable care across the cancer care continuum. His passion for this work is profoundly personal, stemming from his experience as a caregiver.
His doctoral research at the University of California, Irvine, which earned him the PhRMA Foundation Predoctoral Fellowship, established a novel framework for incorporating integrative oncology therapies into cancer survivorship from an evidence-, science-, and value-based perspective.
At Yale, he continues his research by developing expertise at the intersection of pharmacoepidemiology and decision science. His current work focuses on quantifying the value of new therapies and underutilized interventions in clinical oncology and hematology to inform evidence-based practice, improve patient outcomes, enhance healthcare decision making, and optimize healthcare resource allocation.
Education & Training
- PhD
- University of California, Irvine, Pharmaceutical Sciences (Cancer Survivorship and Supportive Care) (2025)
- BSc (Hon)
- National University of Singapore, Pharmacy (2019)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0002-0754-7901- View Lab Website
Goshua Lab
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Satoko Ito, MD, PhD
George Goshua, MD, SM, FACP
Manraj Singh Sra, MBBS
Daniel Wang
Alfred Lee, MD, PhD
Amer Zeidan, MBBS, MD
Cancer Survivors
Biomarkers
Survivorship
Electronic Health Records
Integrative Oncology
Publications
Featured Publications
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial
Ng D, Heshmatipour M, Trudeau J, Sridhar A, Pluimer B, Drayson O, Lavasani S, Parajuli R, Lee S, Agrawal A, Acharya M, Limoli C, Harris R, Xie L, Malik S, Chan A. Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial. Journal Of The National Cancer Institute 2026, djag096. PMID: 41926740, PMCID: PMC13285686, DOI: 10.1093/jnci/djag096.Peer-Reviewed Original ResearchCitationsAltmetricReal-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
Ng D, Lee S, Lee R, Wang Y, Chan A. Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain. BMC Medicine 2024, 22: 394. PMID: 39285302, PMCID: PMC11406884, DOI: 10.1186/s12916-024-03626-2.Peer-Reviewed Original ResearchCitationsAltmetricDynamin-1 is a potential mediator in cancer-related cognitive impairment
Ng D, Hudson C, Nguyen T, Gupta S, Koh Y, Acharya M, Chan A. Dynamin-1 is a potential mediator in cancer-related cognitive impairment. Neurotherapeutics 2024, 22: e00480. PMID: 39516074, PMCID: PMC11742811, DOI: 10.1016/j.neurot.2024.e00480.Peer-Reviewed Original ResearchCitationsAltmetricSubstance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort
Ng D, Ritt-Olson A, Freyer D, Miller K, Thomas S, Milam J, Chan A. Substance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort. JCO Oncology Practice 2022, 19: e345-e354. PMID: 36508698, PMCID: PMC10022886, DOI: 10.1200/op.22.00458.Peer-Reviewed Original ResearchCitationsAltmetricCurrent and recommended practices for evaluating adverse drug events using electronic health records: A systematic review
Ng D, Dang E, Chen L, Nguyen M, Nguyen M, Samman S, Nguyen T, Cadiz C, Nguyen L, Chan A. Current and recommended practices for evaluating adverse drug events using electronic health records: A systematic review. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2021, 4: 1457-1468. DOI: 10.1002/jac5.1524.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetric
2026
Sociodemographic disparities and reasons for delayed healthcare among U.S. cancer survivors: an All of Us study
Ng D, Zheng Z, Jemal A, Chan A, Islami F. Sociodemographic disparities and reasons for delayed healthcare among U.S. cancer survivors: an All of Us study. Supportive Care In Cancer 2026, 34: 663. PMID: 42303910, PMCID: PMC13272612, DOI: 10.1007/s00520-026-10880-y.Peer-Reviewed Original ResearchAltmetricTrajectory and predictors of cancer- and treatment-related fatigue (CRF) in adolescent and young adult cancer patients: a prospective, longitudinal study
Chan A, Chan D, Agrawal P, Beppu L, Kober K, Ng D, Sayer M, Trudeau J. Trajectory and predictors of cancer- and treatment-related fatigue (CRF) in adolescent and young adult cancer patients: a prospective, longitudinal study. BMC Cancer 2026 PMID: 42304319, DOI: 10.1186/s12885-026-16324-4.Peer-Reviewed Original ResearchComparing the association between out‐of‐pocket cost burden and cost‐related care avoidance among individuals with and without a history of cancer
Liang X, Tay D, Ke Y, Ng D, Patikorn C, Asche C, Chaiyakunapruk N, Kirchhoff A, Chan R, Chan A, Tan C. Comparing the association between out‐of‐pocket cost burden and cost‐related care avoidance among individuals with and without a history of cancer. Cancer 2026, 132: e70495. PMID: 42290381, PMCID: PMC13266579, DOI: 10.1002/cncr.70495.Peer-Reviewed Original ResearchCitationsAltmetricBarriers to effective first-line treatment for women with iron deficiency
Rinaldi K, Ng D, Tadepalli A, Ito S, Goshua G, Wang D. Barriers to effective first-line treatment for women with iron deficiency. Expert Review Of Hematology 2026, ahead-of-print: 1-3. PMID: 42212667, DOI: 10.1080/17474086.2026.2683026.Commentaries, Editorials and LettersJAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis
Lam B, Ito S, Ryu J, O'Sullivan K, Potnis K, Lu R, Bidikian A, Ng D, Singh R, Deter A, Carfagnini C, Bechara S, Kandula M, Do N, Fillmore N, Freed J, Patell R, La J, Goshua G. JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost‐Effectiveness Analysis. American Journal Of Hematology 2026 PMID: 42227164, DOI: 10.1002/ajh.70390.Commentaries, Editorials and Letters
Links
Copy Link
Get In Touch
Copy Link
Contacts
Locations
Yale Cancer Center Decision Science
Academic Office
300 George Street, Ste 900
New Haven, CT 06511
Social Media